Skip to main content
American Journal of Respiratory and Critical Care Medicine logoLink to American Journal of Respiratory and Critical Care Medicine
letter
. 2019 Oct 15;200(8):1070–1071. doi: 10.1164/rccm.201905-1024LE

Understanding Hyperlactatemia in Human Sepsis: Are We Making Progress?

Daniel De Backer 1, Jean-Louis Vincent 1,*
PMCID: PMC6794110  PMID: 31206304

To the Editor:

We have significant concerns about the interpretation of the data presented by Gattinoni and colleagues (1). The reminders that lactic acidosis commonly coexists with renal acidosis and that metabolic acidosis does not necessarily mean acidemia are welcome. Indeed, one should dissociate hyperlactatemia from acidosis because hyperlactatemia can be of hypoxic origin even in the absence of acidosis, and of nonhypoxic origin even when there is acidemia (2). Although we agree with Gattinoni and colleagues that a pH measurement can be misleading, and that lactate concentrations should be measured directly, neither the presence or absence of metabolic acidosis nor the central venous oxygen saturation (ScvO2) value can help identify the origin of hyperlactatemia.

Gattinoni and colleagues also reemphasize the well-known fact that hyperlactatemia can coexist with any value of V.o2/oxygen delivery (V.o2/Do2) (or S[c]vO2). This is in part related to timing, because an increase in Do2 as a result of resuscitative efforts may result in a rapid increase in SvO2 but a much slower decrease in blood lactate levels. More importantly, a normal or high ScvO2 does not necessarily indicate that tissue perfusion is adequate. It is well known that a high SvO2 can be a sign of disease severity and worse prognosis (3). However, a high SvO2 does not always imply a significant alteration in cellular metabolism, as high SvO2 values can be the result of microcirculatory alterations. In our early study demonstrating the occurrence of microvascular alterations in sepsis (4), SvO2 values were identical in patients with sepsis and in other ICU patients, but hyperlactatemia was observed only in patients with septic shock (4). Accordingly, it may be erroneous and even potentially harmful to limit resuscitation efforts in a patient with hyperlactatemia just because his or her ScvO2 values are normal or high. When associated with signs of tissue hypoperfusion, an elevated SvO2 (or ScvO2) does not mean that resuscitation efforts are no longer necessary. We previously reported that elevated SvO2 values did not exclude fluid responsiveness in patients with sepsis and signs of tissue hypoperfusion (5). Similarly, Monnet and colleagues showed that blood lactate and venoarterial Pco2 differences, but not ScvO2, predicted an increase in V.o2 in fluid-responsive patients (6).

Hence, we do not think that the observations by Gattinoni and colleagues should influence the way in which patients with sepsis are managed. Hyperlactatemia associated with other signs of tissue hypoperfusion should encourage attempts to increase Do2 with fluids, transfusions, and/or dobutamine administration, even in the absence of acidemia or when ScvO2 is not reduced.

Supplementary Material

Supplements
Author disclosures

Footnotes

Originally Published in Press as DOI: 10.1164/rccm.201905-1024LE on June 17, 2019

Author disclosures are available with the text of this letter at www.atsjournals.org.

References

  • 1.Gattinoni L, Vasques F, Camporota L, Meessen J, Romitti F, Pasticci I, et al. Understanding lactatemia in human sepsis: potential impact for early management. Am J Respir Crit Care Med. 2019;200:582–589. doi: 10.1164/rccm.201812-2342OC. [DOI] [PubMed] [Google Scholar]
  • 2.Kraut JA, Madias NE. Lactic acidosis. N Engl J Med. 2014;371:2309–2319. doi: 10.1056/NEJMra1309483. [DOI] [PubMed] [Google Scholar]
  • 3.Textoris J, Fouché L, Wiramus S, Antonini F, Tho S, Martin C, et al. High central venous oxygen saturation in the latter stages of septic shock is associated with increased mortality. Crit Care. 2011;15:R176. doi: 10.1186/cc10325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.De Backer D, Creteur J, Preiser JC, Dubois MJ, Vincent JL. Microvascular blood flow is altered in patients with sepsis. Am J Respir Crit Care Med. 2002;166:98–104. doi: 10.1164/rccm.200109-016oc. [DOI] [PubMed] [Google Scholar]
  • 5.Velissaris D, Pierrakos C, Scolletta S, De Backer D, Vincent JL. High mixed venous oxygen saturation levels do not exclude fluid responsiveness in critically ill septic patients. Crit Care. 2011;15:R177. doi: 10.1186/10326. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Monnet X, Julien F, Ait-Hamou N, Lequoy M, Gosset C, Jozwiak M, et al. Lactate and venoarterial carbon dioxide difference/arterial-venous oxygen difference ratio, but not central venous oxygen saturation, predict increase in oxygen consumption in fluid responders. Crit Care Med. 2013;41:1412–1420. doi: 10.1097/CCM.0b013e318275cece. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplements
Author disclosures

Articles from American Journal of Respiratory and Critical Care Medicine are provided here courtesy of American Thoracic Society

RESOURCES